Altered expression of transcription factors NKX6-2 and RUNX3, relative to controls, further emphasizes transcription as a central pathological mechanism in ALS-TD patients (Fig. S11; Supplementary Data 10). The gene discussed is RUNX3; the disease is thanatophoric dysplasia.